Rankings / Metabolic Health

Rosuvastatin / atorvastatin (statins)

Metabolic Health · HMG-CoA reductase inhibitor

Tier S

statinanti-inflammatoryprescription
8.8 / 10
Tier S
Ev 10 Bn 10 Sf 7

Bottom line

Read Off Label grades Rosuvastatin / atorvastatin (statins) as S (8.8/10) based on very strong evidence, very strong benefit magnitude, and a low-med-risk safety profile.

SAMSON 2020 definitively demonstrated that most 'statin myalgia' is nocebo (same symptoms on placebo).

Typical use: Rosuvastatin 5-40 mg/day; atorvastatin 10-80 mg/day PO — Rx.

What this is

SAMSON 2020 definitively demonstrated that most 'statin myalgia' is nocebo (same symptoms on placebo). Rosuvastatin gives the most LDL reduction per mg and has the longest half-life. High-intensity dosing (rosuvastatin 20-40 or atorvastatin 40-80) is the secondary prevention standard. Biohacker hostility to statins vastly outstrips evidence.

Mechanism

Competitive inhibition of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis; upregulates hepatic LDL receptors → reduced circulating LDL-C; also anti-inflammatory (CRP reduction), plaque stabilization, endothelial effects

Dose & route

Rosuvastatin 5-40 mg/day; atorvastatin 10-80 mg/day PO

Common questions

Does Rosuvastatin / atorvastatin (statins) work?
Read Off Label rates the evidence for Rosuvastatin / atorvastatin (statins) as Very Strong and the benefit magnitude as very strong, producing an overall grade of S (8.8/10). SAMSON 2020 definitively demonstrated that most 'statin myalgia' is nocebo (same symptoms on placebo).
Is Rosuvastatin / atorvastatin (statins) safe?
Rosuvastatin / atorvastatin (statins) has a low-med risk profile in published human data. Legal status: Rx. This is not medical advice — see the disclaimer.
What is the typical dose for Rosuvastatin / atorvastatin (statins)?
Rosuvastatin 5-40 mg/day; atorvastatin 10-80 mg/day PO
How does Rosuvastatin / atorvastatin (statins) work?
Competitive inhibition of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis; upregulates hepatic LDL receptors → reduced circulating LDL-C; also anti-inflammatory (CRP reduction), plaque stabilization, endothelial effects

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.